Offer - Urjas Oil for just ₹ 1 X
Mapdox CV 100 Mg/62.5 Mg Tablet is a prescription drug, available for use as Tablet. Secondary and off-label uses of Mapdox CV 100 Mg/62.5 Mg Tablet have also been mentioned below.
The right dosage of Mapdox CV 100 Mg/62.5 Mg Tablet depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Some other side effects of Mapdox CV 100 Mg/62.5 Mg Tablet have been listed ahead. Usually, these side effects of Mapdox CV 100 Mg/62.5 Mg Tablet go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Mapdox CV 100 Mg/62.5 Mg Tablet has a Mild effect for pregnant women and Moderate effect on lactating mothers. Further, the section on Mapdox CV 100 Mg/62.5 Mg Tablet related warnings talks about Mapdox CV 100 Mg/62.5 Mg Tablet's effects on the liver, heart and kidney.
Mapdox CV 100 Mg/62.5 Mg Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Mapdox CV 100 Mg/62.5 Mg Tablet in conditions like Jaundice. The section on Mapdox CV 100 Mg/62.5 Mg Tablet contraindications lists all such conditions.
Drug interactions for Mapdox CV 100 Mg/62.5 Mg Tablet have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Mapdox CV 100 Mg/62.5 Mg Tablet is safe while driving, and is is addictive in nature.
Mapdox CV 100 Mg/62.5 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Mapdox CV 100 Mg/62.5 Mg Tablet safe for pregnant women?
Mapdox Cv has little to no side effects in pregnant women.
Is the use of Mapdox CV 100 Mg/62.5 Mg Tablet safe during breastfeeding?
Mapdox Cv can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Mapdox CV 100 Mg/62.5 Mg Tablet on the Kidneys?
Mapdox Cv can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Mapdox CV 100 Mg/62.5 Mg Tablet on the Liver?
Mapdox Cv may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Mapdox CV 100 Mg/62.5 Mg Tablet on the Heart?
Very few cases of side effects of Mapdox Cv on the heart have been reported.
Mapdox CV 100 Mg/62.5 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Mapdox CV 100 Mg/62.5 Mg Tablet unless your doctor advises you to do so -
Is this Mapdox CV 100 Mg/62.5 Mg Tablet habit forming or addictive?
Mapdox CV 100 Mg/62.5 Mg Tablet is not addictive in nature.
Interaction between Food and Mapdox CV 100 Mg/62.5 Mg Tablet
Taking Mapdox CV 100 Mg/62.5 Mg Tablet with food does not cause any problems.
Interaction between Alcohol and Mapdox CV 100 Mg/62.5 Mg Tablet
No research has been done on this till date. Therefore, it is not known what the effect of taking Mapdox CV 100 Mg/62.5 Mg Tablet with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vantin® (cefpodoxime proxetil )
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311